Tagline
I am founder/CEO and inventor, pioneering in big data for IP and medicine innovation, we have a Phase 3 patented molecule for curing glaucoma blindness, currently look for Series A to develop a patented new formulation for clinical trials.
Bio
I am retinal surgeon, stem cell biologist and ocular transplant specialist by trainings, I have over 25-years of international experience in leading and advising some of the most exciting ophthalmic product development from stem cell and gene therapy to drug discovery and delivery across all broad industry ( GSK, Inotek Pharma, Lineage Cells, Astellas Pharma). Recently I pioneered in big data for medicine innovation solving the most difficutl problem that is the 90% drug failure at billion $ cost over a decade of development. From big data I discovered the first curative solution for treating glaucoma blindness with a new approach, this is a breakthrough therapy with anticipated high success. OTI-2024 represents the best in class MMP platform therapy.. Here is our website: http://ophthalmic-innovation.com.
Location
Boston, Massachusetts, US
Last Active
7 months ago
Name / Logo
Industry
Healthcare
Team Size
1-5 employees
Funding Stage
Series A
Funding Raised
1-5 employees
Annual Revenue
Undisclosed
| Skill | Strength | Explanation |
|---|---|---|
| Founder/CEO | 90 / 100 | Founded Ophthalmic Therapeutic Innovation LLC and developed a patented molecule for curing glaucoma blindness. |
| Big Data in Medicine | 85 / 100 | Pioneered the use of big data for medical innovation, specifically in drug discovery and delivery. |
| Pioneered Breakthrough Therapy | 80 / 100 | Discovered a curative solution for treating glaucoma blindness, representing a breakthrough in therapy. |
| Ophthalmology Product Development | 80 / 100 | Over 25 years of experience in leading and advising ophthalmic product development, including stem cell and gene therapy. |
| Healthcare | 75 / 100 | Extensive experience in the healthcare industry, particularly in ophthalmology. |
Title
Ophthalmic Product Development Advisor
Position Description
Advised on the development of ophthalmic products, focusing on innovative therapies and drug delivery systems.
Accomplishment Notes
Contributed to the development of several key ophthalmic products during tenure.
Title
Research Director
Position Description
Directed research initiatives focused on stem cell therapies for eye diseases.
Accomplishment Notes
Pioneered research that led to significant advancements in ocular transplant techniques.
Title
Consultant
Position Description
Provided consulting services on ophthalmic product development and regulatory strategies.
Accomplishment Notes
Advised on successful product launches and regulatory approvals in the ophthalmic sector.
Title
Founder/CEO
Position Description
Leading the company in developing innovative therapies for glaucoma blindness using big data and patented formulations.
Accomplishment Notes
Successfully developed a Phase 3 patented molecule for curing glaucoma blindness and currently seeking Series A funding for clinical trials.
Title
Senior Scientist
Position Description
Led research projects in stem cell and gene therapy for ophthalmic applications.
Accomplishment Notes
Developed novel approaches to drug discovery and delivery in ophthalmology.